Psychedelics are going mainstream.  Not only is the US FDA supportive of research, dozens of medical studies are proving such treatments could be helpful, including Johns Hopkins Medicine and New York University.  

To date, psilocybin has been found to help treat mental health issues, such as depression, anxiety, obsessive-compulsive disorder, PTSD, and possibly even eating disorders. LSD may be able to help patients with anxiety disorders and other medical issues.  MDMA-assisted therapy could help treat eating disorders, including anorexia and binge eating.

In addition, according to Kevin Matthews, founder of The Society for Psychedelic Outreach, Reform, and Education (SPORE), as quoted by Rolling Stone, “My hope with the Biden administration and other lawmakers is that they’re going to be receptive to having a conversation about psilocybin and other psychedelics,” says Matthews. “We’re facing a global mental health and addiction crisis, and that’s only been accentuated by CV-19 with the lockdowns and business closures and further isolation. We need radical, safe effective solutions to address this emergency before it gets any worse.”